D-Index & Metrics Best Publications
Microbiology
Netherlands
2022

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 101 Citations 37,733 545 World Ranking 82 National Ranking 2

Research.com Recognitions

Awards & Achievements

2022 - Research.com Microbiology in Netherlands Leader Award

Fellow of the European Confederation of Medical Mycology (ECMM)

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Antibiotics

Jacques F. Meis focuses on Microbiology, Aspergillus fumigatus, Aspergillosis, Posaconazole and Voriconazole. Microbiology is a component of his Itraconazole, Amphotericin B, Azole, Fluconazole and Drug resistance studies. His studies deal with areas such as Aspergillus, Fungi imperfecti, Genotype, Fungal protein and Chronic pulmonary aspergillosis as well as Aspergillus fumigatus.

In his study, which falls under the umbrella issue of Genotype, Genotyping is strongly linked to Typing. He has researched Aspergillosis in several fields, including Intensive care medicine, Mycosis and Pathology. The study incorporates disciplines such as Mucormycosis, Mucorales, Caspofungin and Fungicide in addition to Posaconazole.

His most cited work include:

  • Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus (2079 citations)
  • Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses (576 citations)
  • ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013 (543 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Microbiology, Amphotericin B, Voriconazole, Aspergillus fumigatus and Aspergillosis. His Microbiology study typically links adjacent topics like Genotype. His study in Amphotericin B is interdisciplinary in nature, drawing from both Broth microdilution and Pharmacology.

His Aspergillus fumigatus research incorporates themes from Fungi imperfecti, Drug resistance and Aspergillus. His Aspergillosis study combines topics in areas such as Fungemia, Mycosis, Internal medicine and Superinfection. His Fluconazole course of study focuses on Candida auris and Outbreak.

He most often published in these fields:

  • Microbiology (52.16%)
  • Amphotericin B (17.25%)
  • Voriconazole (17.39%)

What were the highlights of his more recent work (between 2017-2021)?

  • Microbiology (52.16%)
  • Candida auris (8.21%)
  • Aspergillus fumigatus (16.69%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Microbiology, Candida auris, Aspergillus fumigatus, Voriconazole and Azole. Much of his study explores Microbiology relationship to Genotype. The various areas that Jacques F. Meis examines in his Candida auris study include Infection control, Corpus albicans, Intensive care, Outbreak and Internal medicine.

His work carried out in the field of Aspergillus fumigatus brings together such families of science as Bronchoalveolar lavage, Genotyping, Aspergillosis and Agar. His Aspergillosis study which covers Aspergillus that intersects with Aspergillus flavus and Intensive care medicine. His Azole research is multidisciplinary, incorporating perspectives in Gene and Drug resistance.

Between 2017 and 2021, his most popular works were:

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline (417 citations)
  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (285 citations)
  • A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. (184 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Bacteria

His main research concerns Microbiology, Candida auris, Azole, Aspergillus fumigatus and Voriconazole. His research combines Genotype and Microbiology. His Candida auris research integrates issues from Epidemiology, Infection control, Outbreak, Public health and Virulence.

The Aspergillus fumigatus study combines topics in areas such as Fungicide, Resistance, Agar, Antifungal and Aspergillosis. His Voriconazole research is multidisciplinary, relying on both Itraconazole and Susceptibility testing. The various areas that Jacques F. Meis examines in his Amphotericin B study include Fusarium and Pharmacology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

S. Ascioglu;J. H. Rex;B. de Pauw;J. E. Bennett.
Clinical Infectious Diseases (2002)

2739 Citations

Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

Shawn R. Lockhart;Kizee A. Etienne;Snigdha Vallabhaneni;Joveria Farooqi.
Clinical Infectious Diseases (2017)

750 Citations

Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria

R. Agarwal;A Chakrabarti;A. Shah;D. Gupta.
Clinical & Experimental Allergy (2013)

586 Citations

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning.
Clinical Microbiology and Infection (2018)

563 Citations

ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

O.A. Cornely;S. Arikan-Akdagli;E. Dannaoui;A.H. Groll.
Clinical Microbiology and Infection (2014)

543 Citations

Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007

A. Skiada;L. Pagano;A. Groll;S. Zimmerli.
Clinical Microbiology and Infection (2011)

520 Citations

A primer on cytokines: sources, receptors, effects, and inducers.

J.H.A.J. Curfs;J.F.G.M. Meis;J.A.A. Hoogkamp-Korstanje.
Clinical Microbiology Reviews (1997)

451 Citations

First hospital outbreak of the globally emerging Candida auris in a European hospital

Silke Schelenz;Ferry Hagen;Johanna L. Rhodes;Alireza Abdolrasouli.
Antimicrobial Resistance and Infection Control (2016)

438 Citations

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach.
Clinical Infectious Diseases (2020)

431 Citations

Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

Paul E. Verweij;Anuradha Chowdhary;Willem J. G. Melchers;Jacques F. Meis.
Clinical Infectious Diseases (2016)

424 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jacques F. Meis

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 194

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 194

David W. Denning

David W. Denning

University of Manchester

Publications: 171

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 168

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 157

Olivier Lortholary

Olivier Lortholary

Université Paris Cité

Publications: 157

Teun Boekhout

Teun Boekhout

University of Amsterdam

Publications: 127

Kieren A. Marr

Kieren A. Marr

Johns Hopkins University School of Medicine

Publications: 123

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 119

Arunaloke Chakrabarti

Arunaloke Chakrabarti

Post Graduate Institute of Medical Education and Research

Publications: 117

Eric Dannaoui

Eric Dannaoui

Université Paris Cité

Publications: 110

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 108

Nathan P. Wiederhold

Nathan P. Wiederhold

The University of Texas Health Science Center at San Antonio

Publications: 107

John R. Perfect

John R. Perfect

Duke University

Publications: 106

Russell E. Lewis

Russell E. Lewis

University of Bologna

Publications: 105

Stéphane Bretagne

Stéphane Bretagne

Université Paris Cité

Publications: 99

Trending Scientists

Martin Jones

Martin Jones

Liverpool John Moores University

Danny H.W. Li

Danny H.W. Li

City University of Hong Kong

Marios C. Papaefthymiou

Marios C. Papaefthymiou

University of Michigan–Ann Arbor

Tamer Khatib

Tamer Khatib

An-Najah National University

Petr Nachtigall

Petr Nachtigall

Charles University

José M. C. Ribeiro

José M. C. Ribeiro

National Institutes of Health

Raymond J. Monnat

Raymond J. Monnat

University of Washington

Joshua M. Shulman

Joshua M. Shulman

Baylor College of Medicine

James R. Dick

James R. Dick

University of Stirling

Alireza R. Rezaie

Alireza R. Rezaie

Oklahoma Medical Research Foundation

Robert W. Dalrymple

Robert W. Dalrymple

Queen's University

Karl Fuchs

Karl Fuchs

Karlsruhe Institute of Technology

Manika Prasad

Manika Prasad

Colorado School of Mines

Pietro Teatini

Pietro Teatini

University of Padua

Gernot Riedel

Gernot Riedel

University of Aberdeen

Ralph J. DiLeone

Ralph J. DiLeone

Yale University

Something went wrong. Please try again later.